Canine Parvovirus Clinical Trial Completed
Results:
|
Progress Level |
%100 – Work Completed |
|
|
|
|
Dr Biolyse® Treatment Effectiveness Rate |
%100 |
|
Dr Biolyse® Group Mortality |
%0 |
|
|
|
|
Standard Treatment Effectiveness Rate |
%30 |
|
Standard Treatment Group Mortality Rate |
%70
|
Scope of Treatment Effectiveness:
While the Antiviral effect is observed on the virus,
Deteriorated hematological values returned to normal,
The patients who had completely stopped hemorrhagic diarrhea and vomiting due to infection were discharged.
No serious adverse effects were found.
The clinical trial has been completed.
March 2022